AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2011
May 2, 2011
32227_dirs_2011-05-02_32337cd9-a398-4f09-a2f1-1bb06fe92033.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2011-05-02
Reporting Person: SMITS MARK W (Chief Commercial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6667 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock option(Right to Buy) | $1.02 | 2015-08-30 | Common Stock (425000) | Direct |
Footnotes
F1: On August 30, 2010 Mr. Smits was granted an option to purchase 425,000 shares. The first date options became exercisable and vested was August 30, 2010. The options are a combination of time based and performance options. Within 60 days of this filing 45,000 options are exercisable and vested.
More from NEOGENOMICS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24